Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
ECO 24: Long-Term Weight Loss in the SELECT trial
Author(s): Donna H Ryan Added: 1 year ago
ECO 2024 — Dr Donna H Ryan (Pennington Biomedical Research Center, US) joins us to discuss the first sub-analysis of the landmark SELECT trial (NCT03574597, Novo Nordisk).In this study, investigators looked at long-term weight loss with semaglutide 2.4 mg compared to a placebo among 17,604 participants. In SELECT, at 208 weeks, semaglutide produced clinically significant weight loss compared to… View more

Heart Failure

Prevention & Chronic Conditions
Heart Failure Nurses within the Primary Care Setting
Author(s): Loreena Hill , Anne McNulty , James McMahon , et al Added: 2 years ago

Heart Failure

Digital Health
EMPA-KIDNEY: Empagliflozin in Patients with Chronic Kidney Disease
Author(s): William Herrington Added: 1 year ago
Long-term cardio-renal outcomes investigating empagliflozin (Boehringer Ingelheim) on kidney disease progression (KDP) or cardiovascular death in patients with pre-existing chronic kidney disease.In this short interview, Prof William Herrington (Nuffield Department of Population Health, University of Oxford, Oxford, UK) discusses the findings from EMPA-KIDNEY (NCT03594110).EMPA-KIDNEY is an… View more

Prevention & Chronic Conditions

Cardiovascular Renal Metabolic
STEP: Early Intensive BP Control Shows Long-Term Benefit
Added: 4 months ago Source:  Radcliffe Cardiology
New long-term data from the Strategy of Blood Pressure Intervention in the Elderly Hypertensive Patients (STEP) trial suggests that sustained, intensive blood pressure (BP) control provides greater cardiovascular benefits compared to a delayed approach in older patients with hypertension.¹ The findings also indicate that the earlier intensive treatment is initiated, the greater the reduction in… View more

Demographic

Heart Failure
Long-Term Survival Benefit Associated with CRT-D Compared to ICD in HF in the RAFT Trial
Added: 2 years ago Source:  Radcliffe Cardiology
AUTHOR: Brad WilsonRAFT, a new extended follow-up trial (NCT00251251) showed insight into the survival benefit associated with coronary resynchronization therapy defibrillator (CRT-D) as compared to implantable cardioverter-defibrillator (ICD) in patients with heart failure.Methodology:The Resynchronization/Defibrillation for Ambulatory Heart Failure Trial (RAFT) is a randomized trial which aimed… View more
Breakthrough Mineralocorticoid Receptor Agonists in Cardiovascular Care
Author(s): Javed Butler , Dinesh Khullar , John JV McMurray , et al Added: 3 months ago
In this expert-led webinar moderated by Dr Vijay Chopra, leading clinicians review current and emerging strategies in aldosterone modulation, hyperkalaemia management, and cardiorenal therapeutics.Dr Javed Butler opens with a practical overview of aldosterone’s central role in heart failure and CKD, emphasising the importance of achieving guideline-directed RAAS inhibitor and MRA dosing. He… View more

Prevention & Chronic Conditions

Heart Failure
Advancing Patient Care in Hypertrophic Cardiomyopathy: Key Insights from the HFA 2024
Author(s): Ahmad Masri , Added: 1 year ago
Recorded during HFA 2024, Dr Caroline Coats, Glasgow University, UK, and Dr Ahmad Masri, Oregon Health and Science University, US, collaborate to explore the pivotal advancements in managing hypertrophic cardiomyopathy unveiled at the conference.This programme is thoughtfully divided into four chapters, facilitating a smooth journey through the latest HCM trial data, including a comprehensive… View more

Guidelines & Statements

Heart Failure
Implementing Heart Failure Guidelines with Collaborative Care
Author(s): Carolyn Lam , Carys Barton , Stephen J Greene , et al Added: 2 years ago
This satellite symposium, chaired by Prof Carolyn Lam (National Heart Centre Singapore, SG), provides an excellent opportunity to learn about the latest guideline recommendations in HFpEF and how to implement them effectively in clinical practice. The panel of experts, including Dr Gianluigi Savarese (Karolinska Institute, Stockholm, SE), Dr Stephen Greene (Duke University School of… View more

Guidelines & Statements

Heart Failure
Advancing Heart Failure Care: Timely Referral and Life‑prolonging Strategies with HeartMate 3 Left Ventricular Assist Device
Author(s): Sanjeev Gulati Added: 3 months ago

Heart Failure
Comparison of Haemodynamic Responses to Landiolol Versus Esmolol
Author(s): Georgios Koukoulitsios , Kyriaki Tsikritsaki , Georgios Magklaras , et al Added: 9 months ago

Heart Failure

Vascular Disease and Surgery